Sign in
4

Changes in Ownership

Krystal Biotech, Inc. Filed Acc 0001209191-19-037449

Options or other derivatives

  • Chief Financial Officer acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Riley Antony A · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-06-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +25,000 25,000 D
Loading xslF345X03/doc4.xml…